rat mab anti egr1 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
rat mab anti egr1
Rat Mab Anti Egr1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+mab+anti+egr1/Human+EGR1+Antibody/pmc12546648-114-15-20
Average 93 stars, based on 3 article reviews
Rat Mab Anti Egr1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+mab+anti+egr1/Human+EGR1+Antibody/pmc12546648-114-15-20
Average 93 stars, based on 3 article reviews
rat mab anti egr1 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Formalin-fixed Paraffin-Embedded:Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma. Article Snippet: This was followed by reaction with the three secondary antibodies (1 h at 22 °C): donkey anti-rat Alexa FluorTM Plus 488 (5 μg/ml, Thermo A48269), donkey anti-mouse Alexa FluorTM Plus 647 (5 μg/ml, Thermo A32787), and donkey anti-rabbit Alexa FluorTM 568 (5 μg/ml, Thermo A10042), and DAPI nuclear stain. .. Triple-labeling for EGR1, Ki67 and human nucleoli on FFPE sections utilized the following primary antibodies: Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma. Article Snippet: Sections were stained for SOX10 with rabbit anti-SOX10 (1.5 μg/ml, Sigma-Aldrich, 383 A-74) after permeabilization with 0.25% Triton-X-100 for 15 min. Rabbit IgG was substituted for the first antibody as the negative control. .. Triple-labeling for EGR1, Ki67 and human nuclei on frozen and on FFPE sections Triple-labeling for EGR1, Ki67 and human nuclei on frozen sections utilized the following primary antibodies: Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma Article Snippet: This was followed by reaction with the three secondary antibodies (1 h at 22 °C): donkey anti-rat Alexa Fluor TM Plus 488 (5 μg/ml, Thermo A48269), donkey anti-mouse Alexa Fluor TM Plus 647 (5 μg/ml, Thermo A32787), and donkey anti-rabbit Alexa Fluor TM 568 (5 μg/ml, Thermo A10042), and DAPI nuclear stain. .. Triple-labeling for EGR1, Ki67 and human nucleoli on FFPE sections utilized the following primary antibodies: Incubation:Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma. Article Snippet: This was followed by reaction with the three secondary antibodies (1 h at 22 °C): donkey anti-rat Alexa FluorTM Plus 488 (5 μg/ml, Thermo A48269), donkey anti-mouse Alexa FluorTM Plus 647 (5 μg/ml, Thermo A32787), and donkey anti-rabbit Alexa FluorTM 568 (5 μg/ml, Thermo A10042), and DAPI nuclear stain. .. Triple-labeling for EGR1, Ki67 and human nucleoli on FFPE sections utilized the following primary antibodies: Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma. Article Snippet: .. Double labeling for EGR1 and α7-nAChR for IF studies This utilized the following primary antibodies: Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma Article Snippet: .. This utilized the following primary antibodies: Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma Article Snippet: This was followed by reaction with the three secondary antibodies (1 h at 22 °C): donkey anti-rat Alexa Fluor TM Plus 488 (5 μg/ml, Thermo A48269), donkey anti-mouse Alexa Fluor TM Plus 647 (5 μg/ml, Thermo A32787), and donkey anti-rabbit Alexa Fluor TM 568 (5 μg/ml, Thermo A10042), and DAPI nuclear stain. .. Triple-labeling for EGR1, Ki67 and human nucleoli on FFPE sections utilized the following primary antibodies: Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma Article Snippet: Sections were stained for SOX10 with rabbit anti-SOX10 (1.5 μg/ml, Sigma-Aldrich, 383 A-74) after permeabilization with 0.25% Triton-X-100 for 15 min. Rabbit IgG was substituted for the first antibody as the negative control. .. Triple-labeling for EGR1, Ki67 and human nuclei on frozen sections utilized the following primary antibodies: Staining:Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma. Article Snippet: .. Sections were stained for EGR1 with Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma Article Snippet: .. Sections were stained for EGR1 with Negative Control:Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma. Article Snippet: .. Sections were stained for EGR1 with Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma Article Snippet: .. Sections were stained for EGR1 with Labeling:Article Title: Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma. Article Snippet: .. Double labeling for EGR1 and α7-nAChR for IF studies This utilized the following primary antibodies: |